找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Delta Opioid Receptor Pharmacology and Therapeutic Applications; Emily M. Jutkiewicz Book 2018 Springer International Publishing AG, part

[復制鏈接]
查看: 41295|回復: 53
樓主
發(fā)表于 2025-3-21 19:22:47 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Delta Opioid Receptor Pharmacology and Therapeutic Applications
編輯Emily M. Jutkiewicz
視頻videohttp://file.papertrans.cn/266/265015/265015.mp4
概述Discusses emerging knowledge about the biological function of the delta opioid receptor.Describes therapeutic potential of the delta opioid receptor system.Describes unique trafficking and signaling p
叢書名稱Handbook of Experimental Pharmacology
圖書封面Titlebook: Delta Opioid Receptor Pharmacology and Therapeutic Applications;  Emily M. Jutkiewicz Book 2018 Springer International Publishing AG, part
描述This volume describes our current understanding of the biological role of the delta-opioid receptor (DOR) system, focusing on its unique mechanisms of receptor trafficking and signaling in disease states. Part 1 covers the endogenous ligands that regulate the DOR system as well as novel compounds and therapies used to modulate the DOR system. Part 2 describes new insights into the localization and trafficking of the DOR and how ligand-directed signaling alters the fate of the receptor. Part 3 concentrates on the potential role of the DOR system in disease states, such as pain, mood, addiction, and Parkinson’s disease. Throughout the book, the DOR system as a target for drug development will be discussed.
出版日期Book 2018
關鍵詞CNS-related diseases; Enkephalin; biased agonism; drug development; pain, emotion and addiction; receptor
版次1
doihttps://doi.org/10.1007/978-3-319-95133-1
isbn_softcover978-3-030-06980-3
isbn_ebook978-3-319-95133-1Series ISSN 0171-2004 Series E-ISSN 1865-0325
issn_series 0171-2004
copyrightSpringer International Publishing AG, part of Springer Nature 2018
The information of publication is updating

書目名稱Delta Opioid Receptor Pharmacology and Therapeutic Applications影響因子(影響力)




書目名稱Delta Opioid Receptor Pharmacology and Therapeutic Applications影響因子(影響力)學科排名




書目名稱Delta Opioid Receptor Pharmacology and Therapeutic Applications網絡公開度




書目名稱Delta Opioid Receptor Pharmacology and Therapeutic Applications網絡公開度學科排名




書目名稱Delta Opioid Receptor Pharmacology and Therapeutic Applications被引頻次




書目名稱Delta Opioid Receptor Pharmacology and Therapeutic Applications被引頻次學科排名




書目名稱Delta Opioid Receptor Pharmacology and Therapeutic Applications年度引用




書目名稱Delta Opioid Receptor Pharmacology and Therapeutic Applications年度引用學科排名




書目名稱Delta Opioid Receptor Pharmacology and Therapeutic Applications讀者反饋




書目名稱Delta Opioid Receptor Pharmacology and Therapeutic Applications讀者反饋學科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-21 23:41:22 | 只看該作者
Multifunctional Opioid Ligands,the treatment of many different conditions, including pain, depression, and addiction. However, stimulation or blockade of any one opioid receptor type often leads to on-target adverse effects that limit the clinical utility of a selective opioid agonist or antagonist. Literature precedent suggests
板凳
發(fā)表于 2025-3-22 01:55:53 | 只看該作者
地板
發(fā)表于 2025-3-22 05:36:59 | 只看該作者
5#
發(fā)表于 2025-3-22 10:06:19 | 只看該作者
Delta Opioid Receptor Expression and Function in Primary Afferent Somatosensory Neurons, somatosensory experiences, from shooting pain to pleasant touch. In recent years, the identification of dozens of genetic markers specifically expressed by subpopulations of DRG neurons has dramatically improved our understanding of this diversity and provided the tools to manipulate their activity
6#
發(fā)表于 2025-3-22 14:58:15 | 只看該作者
7#
發(fā)表于 2025-3-22 18:25:20 | 只看該作者
8#
發(fā)表于 2025-3-22 22:16:01 | 只看該作者
9#
發(fā)表于 2025-3-23 02:33:25 | 只看該作者
Delta Opioid Receptors and Modulation of Mood and Emotion,gh opioids have long been known to regulate mood states, the use of opioids to treat depression is rarely discussed. This chapter explores the preclinical and clinical evidence supporting the antidepressant-like effects of opioid ligands, and in particular, delta opioid receptor (DOR) agonists. DOR
10#
發(fā)表于 2025-3-23 07:48:56 | 只看該作者
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2026-1-27 08:05
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
吉林省| 会东县| 连城县| 临猗县| 金门县| 宁德市| 永宁县| 杂多县| 鄂州市| 光山县| 阳信县| 清水河县| 静乐县| 两当县| 博兴县| 西乡县| 江山市| 宣汉县| 清徐县| 平乐县| 大同县| 大洼县| 丁青县| 望江县| 蒲江县| 新竹市| 贵溪市| 改则县| 原阳县| 清徐县| 科技| 分宜县| 乃东县| 沾益县| 连江县| 鹤峰县| 安顺市| 台南市| 大姚县| 汝城县| 安徽省|